Products
Latest Partnered Companies
.jpg){kind=logo}
Projects
Estimated Cost :
$365 million
Amgen to build new Manufacturing Facility in U.S
Amgen recently announced plans to expand its U.S.-based manufacturing footprint by building a new, final product advanced assembly and packaging plant...
Estimated Cost :
€165 Million
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain
BD to build a €165 million high-tech manufacturing facility in the city of Zaragoza, located in the Aragon region of Spain
Estimated Cost :
-
Samsung Biologics Constructs Super Plant 4 in South Korea
Samsung Biologics plans to open the most innovative biomanufacturing facility with the addition of super plant 4. The modern super plant 4 will be loc...
Estimated Cost :
€400 million
Sanofi to invest €400 million to Create a Unique Vaccine Production Site in Singapore
Sanofi announced a €400 million investment over five years to create a unique vaccine production
Press Release
Forge Biologics Announces FDA and EMA Regulatory Updates, Speeding Manufacturing and Clinical Trials
Forge Biologics, a gene therapy-oriented contract development and manufacturing organization, today announced that it has received additional designations and regulatory comments from the Agency European Medicines Agency (EMA) and the United States Food & Drug Administration (FDA), thereby accelerating the manufacturing capabilities
Genmab and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer
Genmab A/S and Seagen Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to TIVDAK™ (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate (ADC) for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to Humira
Alvotech today welcomed the positive opinion of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending the approval of Alvotech‘s high-concentration AVT02 (100 mg/mL), a proposed biosimilar to Humira® (adalimumab). The CHMP’s positive opinion will now be referred to the European Commission
Exelixis Announces Detailed Phase 1b Results from Cohort 6 of COSMIC-021 Trial in Patients with Metastatic Castration-Resistant Prostate Cancer Presented at ESMO 2021
Exelixis, Inc. today announced detailed results from the expanded cohort 6 of the phase 1b COSMIC-021 trial of cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer (CRPC). Cohort 6 included patients with metastatic CRPC who had been previously treated with the novel hormone therapies (NHT) enzalutamide and/or abiraterone acetate used along with prednisone.
Events
SMi’s inaugural Oligonucleotide Therapeutics and Delivery
Healthcare Automation and Digitalization Congress 2021
.jpg)
Articles
Top 12 Analytical Lab Equipments in Pharmaceutical Industry
The analytical lab equipments or instruments are used in analytical applications in pharmaceutical, food-processing laboratories
A Complete Guide on Blister Packaging Machine
Packaging machinery is one of the vital equipment in the pharmaceutical industry, food processing, and chemical
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Focus on drug discovery and development has shifted away from small to large, complex molecular entities
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
See your banner here...
.jpg)
Thank you for contacting us. One of our support staff will get in touch with you shortly.
Happy Surfing!
Regards,
Client Success Team (CRM),
